Summary
Infection of rhabdomyosarcoma (RD) cells by coxsackie B5 virus (CBV5) was non-cytopathic, although low titres of infectious virus were produced after 24 h post-infection. The extent of CBV5 replication in RD cells increased after sequential passage of the virus in these cells. The RD cells from the first cycle of CBV5 infection were recovered and maintained in culture for 3 months (equivalent to 21 passages) releasing infectious virus throughout this period; these cells were considered to be persistently infected with CBV5 and were designated piRD cells. Coxsackie virus antigen was demonstrated in a small proportion of piRD cells by immunofluorescence staining. High resolution two-dimensional polyacrylamide gel electrophoresis was used to analyse the intracellular proteins prepared from piRD cells, three proteins were detected which were absent in uninfected RD cells. These new proteins were similar in charge to virus proteins induced during CBV5 lytic infection of HEp-2 cells. Quantitative densitometry of 2-dimensional protein profiles of piRD and uninfected cells showed no significant disruption of RD cell protein synthesis by the persistent virus infection. Three cloned cell lines were recovered from piRD cells, none of which showed evidence of infectious virus or virus-induced protein synthesis suggesting that the parental cell line was a carrier culture for CBV5.
Similar content being viewed by others
References
Bowles NE, Richardson PJ, Olsen EGJ, Archard LC (1986) Detection of coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet i: 1120–1123
Bureau JF, Chirinian S, Ozden S, Aubert C, Brahic M (1990) Isolation of a specific cellular mRNA by subtractive hybridization in Theiler's virus persistent infection. Microb Pathog 8: 335–341
Cao Y, Schnurr DP (1988) Persistent infection of YAC-1 cells by coxsackievirus B3. J Gen Virol 69: 59–65
Cao Y, Schnurr DP, Schmidt NJ (1984) Monoclonal antibodies for the study of antigenic variation in coxsackievirus type B4: association of antigenic determinants with myocarditic properties of the virus. J Gen Virol 65: 925–932
Cao Y, Walen KH, Schnurr D (1988) Coxsackievirus B3 selection of virus resistant buffalo green monkey kidney cells and chromosome analysis of parental and resistant cells. Arch Virol 101: 209–219
Cao Y, Yagi S, Schnurr D (1989) Persistent infections by coxsackievirus B3. In: Aiuti F (ed) Pathogenesis and control of viral myocarditis. Raven Press, New York, pp 105–112 (Serono Symposia Publications, vol 59)
Cash P (1988) Structural and antigenic variation of the structural protein VP 3 in serotype 1 poliovirus isolated from vaccinees. Can J Microbiol 34: 802–806
Cash P (1989) Analysis of virus protein heterogeneity among group B coxsackie viruses using a “mini” two-dimensional gel electrophoresis system. Electrophoresis 10: 793–800
Cash P (1991) The application of two-dimensional polyacrylamide gel electrophoresis to medical microbiology: molecular epidemiology of viruses and bacteria. Electrophoresis 12: 592–604
Cash P, Wunner WH, Pringle CR (1977) A comparison of the polypeptides of human and bovine respiratory syncytial viruses and murine pneumonia virus. Virology 82: 369–379
Chatterjee NK, Nejman C (1988) Insulin mRNA content in pancreatic beta cells of coxsackievirus B4-induced diabetic mice. Mol Cell Endocrinol 55: 193–202
Colbere-Garapin F, Christodoulou C, Crainic R, Pelletier I (1989) Persistent poliovirus infection of human neuroblastoma cells. Proc Natl Acad Sci USA 86: 7590–7594
Crowell RL (1963) Specific viral interference in HeLa cell cultures chronically infected with coxsackie B5 virus. J Bacteriol 86: 517–526
Cunningham L, Bowles NE, Lane RJM, Dubowitz V, Archard LC (1990) Persistence of enteroviral RNA in chronic fatigue syndrome is associated with the abnormal production of equal amounts of positive and negative strands of enteroviral RNA. J Gen Virol 71: 1399–1402
de la Torre JC, Davila M, Sobrino F, Ortin J, Domingo E (1985) Establishment of cell lines persistently infected with foot-and-mouth disease virus. Virology 145: 24–35
de la Torre JC, Diez J, Villaverde A, Gebaur F, Rocha E, Davila M, Domingo E (1988) Co-evolution of cells and viruses in a persistent infection of foot-and-mouth disease virus in cell culture. J Virol 62: 2050–2058
Frank JA, Shmidt EV, Smith RE, Wilfert CM (1986) Persistent infection of rat insulinoma cells with coxsackie B4 virus. Arch Virol 87: 143–150
Garrels JI, Franza BR (1989) Transformation sensitive and growth-related changes of protein synthesis in REF 52 cells. J Biol Chem 264: 5299–5312
Gibson JP, Righthand VF (1985) Persistence of echovirus 6 in cloned human cells. J Virol 54: 219–223
Gimenez HB, Cash P, Melvin WT (1984) Monoclonal antibodies to human respiratory syncytial virus and their use in comparison of different virus isolates. J Gen Virol 65: 963–971
Giometti CS, Gemmell MA, Nance SL, Tollaksen SL, Taylor J (1987) Detection of heritable mutations as quantitative changes in protein expression. J Biol Chem 262: 12764–12767
Gow JW, Behan WMH, Clements GB, Woodall C, Riding M, Behan PO (1991) Enteroviral RNA sequences detected by polymerase chain reaction in muscle of patients with postviral fatigue syndrome. Br Med J 302: 692–696
Jin O, Sole MJ, Butany JW, Chia W-K, McLaughlin PR, Liu P, Liew C-C (1990) Detection of enterovirus RNA in myocardial biopsies from patients with myocarditis and cardiomyopathy using gene amplification by the polymerase chain reaction. Circulation 82: 8–16
Kettmann JR, Robinson RA, Kuhn L, Lefkovits I (1991) Global analysis of lymphocyte gene expression: perturbations of H-9 cells by infection with distinct isolates of human immunodeficiency virus — an exposition by multivariate analysis of a host parasite interface. Electrophoresis 12: 554–569
Klavinskis LS, Oldstone MB (1989) Lymphocytic choriomeningitis virus selectively alters differentiation but not housekeeping functions: block in expression of growth hormone gene is at the level of transcriptional initiation. Virology 168: 232–235
Matteucci D, Paglianti M, Giangregorio AM, Capobianchi MR, Dianzani F, Bendinelli M (1985) Group B coxsackieviruses readily establish persistent infections in human lymphoid cell line. J Virol 56: 651–654
McAllister RM, Melnyk J, Finkelstein JZ, Adams EC, Gardner MB (1969) Cultivation in vitro of cells derived from a malignant human rhabdomyosarcoma. Cancer 24: 520–526
Moore M, Kaplan MH, McPhee J, Bregman DJ, Klein SW (1984) Epidemiologic, clinical and laboratory features of coxsackie B1-B5 infections in the United States, 1970–1979. Public Health Rep 99: 515–522
Prabhakar BS, Haspel MV, McClintock PR, Notkins AL (1982) High frequency of antigenic variants among naturally occurring human coxsackievirus B4 isolates identified by monoclonal antibodies. Nature 300: 374–376
Reagen KJ, Goldberg B, Crowell RL (1984) Altered receptor specificity of coxsackievirus B3 after growth in rhabdomyosarcoma cells. J Virol 49: 635–640
Roos RP, Richards OC, Green J (1982) Characterisation of a cell culture persistently infected with the DA strain of Theiler's murine encephalomyelitis virus. J Virol 43: 1118–1122
Schmidt NJ, Ho HH, Lennette EH (1975) Propagation and isolation of group A coxsackieviruses in RD cells. J Clin Microbiol 2: 183–185
Schnurr DP, Schmidt NJ (1984) Persistent infection of mouse fibroblasts with coxsackievirus. Arch Virol 81: 91–101
Schnurr DP, Schmidt NJ (1989) Persistent infections. In: Bendinelli M, Friedman H (eds) Coxsackieviruses, a general update. Plenum, New York, pp 181–201
Webb SR, Kearse KP, Foulke CL, Hartig PC, Prabhakar BS (1986) Neutralisation epitope diversity of coxsackievirus B4 isolates detected by monoclonal antibodies. J Med Virol 20: 9–15
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Argo, E., Gimenez, B. & Cash, P. Non-cytopathic infection of rhabdomyosarcoma cells by coxsackie B5 virus. Archives of Virology 126, 215–229 (1992). https://doi.org/10.1007/BF01309696
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01309696